The Inflation Reduction Act has decreased Medicare Part D expenditures and the total cost of care under the Enhancing Oncology Model but has not reduced total drug spending, data suggest.
The U.S. Congressional Budget Office said on Monday that new exemptions to drug price negotiations for several blockbuster ...
America cannot afford to continue subsidizing a failing health care plan. Ending the Obamacare subsidies should be an easy ...
The Congressional Budget Office says exemptions for orphan drugs as part of Medicare price negotiations will cost taxpayers ...
Heavy discounts on new electric vehicles and buyer skepticism about their durability continue to push down used EV prices, which experts say has opened up a traditionally pricey market to more ...
On Thursday, Attorney General Jeff Jackson joined 21 other states and the District of Columbia in suing the Environmental ...
With over 571,000 Kansas residents depending on Medicare for health coverage, now is the critical time to act. The annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback